Answers are grounded in this paper and cite their sources.
This research demonstrates equivalent performance in ischemia detection between digital and analog ECG systems, indicating potential for wider clinical use.
Abstract High-frequency electrocardiography (HF-ECG) in the 100–500 Hz range enhances ischemia detection by capturing microvolt-level QRS changes, yet its clinical adoption requires the validation of digital systems against analog standards. HF-ECG signals were recorded simultaneously from 12 healthy subjects (84 beats total) using a 5-stage analog system (100–500 Hz bandpass, gold connectors) and Sydäntek’s 10x capacitive sensors, both digitized via Texas Instruments ADS1298. Signals underwent 10x amplification (low-noise op-amp), with analog scaled to match, and were processed by PulseTek™ and stored in PulseVault™. Amplitude, root mean square (RMS), kurtosis, and frequency content were analyzed using Bland-Altman methods, with analog as the standard; values reflect pre-amplified measurements in microvolts (µV). Mean differences (analog minus Sydäntek) were minimal—RMS: 6.39 µV (95% LOA: -49.74 to 62.52 µV), amplitude: 1.82 µV (-57.09 to 60.73 µV), kurtosis: 1.93 (-5.13 to 1.54), frequency: 2.1 Hz (-5.8 to 6.2 Hz)—all within 5% clinical tolerance when scaled 10x (~ 10–20 mV). Sydäntek matched analog fidelity, with frequency peaks at ~ 150 Hz. Sydäntek’s digital HF-ECG performance is equivalent to analog systems, validated by tight agreement in key metrics. Its wearable design and cloud integration via PulseVault™ and PulseTek™ offer a portable, reliable alternative for ischemia detection, supporting broader clinical applications.
No takes yet. Share an insight, caveat, or question.
SRINIVA et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: